Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma

E-ISSN： 1875-5992|10|3|225-235

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.3, 2010-03, pp. : 225-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

By Santoni Matteo De Tursi Michele Felici Alessandra Lo Re Giovanni Ricotta Riccardo Ruggeri Enzo Maria Sabbatini Roberto Santini Daniele Vaccaro Vanja Milella Michele

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 697-709

Informa Healthcare

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah Larkin James Pickering Lisa

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies

By Golshayan Ali-Reza Brick Ashley J Choueiri Toni K

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 85-92

Future Medicine

Access to resources Recommend Favorite

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

By Pal Sumanta

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 5-16

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma

By Padrik Peeter

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite